Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Philip Poortmans"'
Autor:
Philip Poortmans, Marjolein L. Smidt, M. Moossdorff, Luc J. A. Strobbe, Sabine Siesling, MC van Maaren
Publikováno v:
Cancer Research. 79:P1-08
Background Survival estimates valid at the time of diagnosis are of limited value for (ex-)breast cancer patients who survived several years, as it includes information on already deceased patients. This study analyzed the 10-year conditional risk of
Autor:
Maria Luisa Gasparri, Jana De Boniface, Oreste Davide Gentilini, Orit Kaidar-Person, Philip Poortmans, Thorsten Kuehn
Publikováno v:
Cancer Research. 82:P1-01
Background: Consensus on the axillary management in cN+ breast cancer patients whoconvert to ycN0 after primary systemic treatment (PST) is still lacking. A surveywas conducted to investigate the clinical practice in this setting. Materials and Metho
Autor:
Charlotte Proudhon, Frédérique Berger, A Vincent-Salomon, J-Y Pierga, Philip Poortmans, F. Mignot, Y.M. Kirova, F-C Bidard, Sylvain Dureau, Delphine Loirat
Publikováno v:
Cancer Research. 78:P4-09
Background: Early stage breast cancer patients with micrometastatic spread (cM0(i+) per the 2010 TNM staging), detected either in the bone marrow (disseminated tumor cells, DTC) or in the blood (circulating tumor cells, CTC) are at higher risk of dis
Autor:
M.C. Falcou, P. Beuzeboc, Alain Fourquet, F Salviat, K.I. Cao, Fatima Laki, L. Bazire, Y.M. Kirova, Alexia Savignoni, Philip Poortmans
Publikováno v:
Cancer Research. 78:P2-11
Background: Breast cancer (BC) management in older women requires an individual approach and is becoming increasingly topical given the aging population. Postoperative radiation therapy (RT) is a standard treatment of BC after breast-conserving-surge
Autor:
Y.M. Kirova, Anne Stilhart, E. Bronsart, Alain Fourquet, Frédérique Berger, H.P. Xu, A. Chilles, Sylvain Dureau, Philip Poortmans, E. Costa
Publikováno v:
Cancer Research. 78:P2-11
Background and Purpose: We previously confirmed the efficacy and safety of our technique of whole breast radiation therapy (WBRT) in isocentric lateral decubitus (ILD) position. The purpose of this work is to evaluate the risk factors for long-term f
Autor:
John H. Maduro, MC van Maaren, H. Struikmans, R. Bretveld, Kcgm Groothuis-Oudshoorn, Sabine Siesling, Philip Poortmans, Renske K. Veenstra, Jan J. Jobsen, Lja Strobbe
Publikováno v:
Cancer Research. 77:P1-10
Background In the Netherlands, one of the indicators of quality of care is that radiation therapy (RT) should start within six weeks following breast-conserving surgery (BCS). However, there is still much controversy regarding timing of RT in literat
Autor:
GS Sonke, Annemieke Witteveen, L. de Munck, Liesbeth J. Boersma, Philip Poortmans, Sabine Siesling, Joost M. Klaase, Maarten Joost IJzerman, K Groothuis-Oudshoorn
Publikováno v:
Cancer Research. 77:P6-09
This abstract was not presented at the symposium.
Autor:
Sabine Siesling, Lja Strobbe, Philip Poortmans, MC van Maaren, M.M.A. Tilanus-Linthorst, M. Lagendijk, L.B. Koppert, S. Saadatmand
Publikováno v:
Cancer Research. 77:P1-11
This abstract was withdrawn by the authors.
Autor:
T. Kuehn, Philip Poortmans, Michael D. Mueller, Malgorzata Banys-Paluchowski, Francesco Meani, Maria Luisa Gasparri, Yves Harder, Valerio Vitale, Andrea Papadia, Daniel Schmauss, Isabel T. Rubio, Oreste Gentilini, Orit Kaidar-Pearson, Beat Thuerlimann, Stefania Rizzo, Claudia Rauh, Diana Lueftner
Publikováno v:
Cancer Research. 81:OT-23
Background: Proper patient selection is crucial to maximize aestethic outcome in breast reconstructive surgery. No specific patients selection criteria have been developed to choose between prepectoral versus subpectoral implant-based reconstruction.
Autor:
MC van Maaren, G. H. de Bock, Sabine C. Linn, L. de Munck, Jan J. Jobsen, Lja Strobbe, Philip Poortmans, T. van Dalen, Sabine Siesling
Publikováno v:
Cancer Research. 76:S3-05
Background: Randomised controlled trials have shown that breast conserving therapy (conserving surgery with radiation therapy, BCT) has equal overall survival (OS) rates as mastectomy without radiation therapy (MAST) in early stage breast cancer. How